Status:
COMPLETED
A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)
Lead Sponsor:
Astellas Pharma Inc
Conditions:
Lower Urinary Tract Symptoms
Bladder Outlet Obstruction
Eligibility:
MALE
45+ years
Phase:
PHASE2
Brief Summary
This study examined the safety, tolerability, and efficacy of mirabegron (YM178) compared to placebo.
Eligibility Criteria
Inclusion
- Men 45 years of age or older
- Documented bladder outlet obstruction
Exclusion
- History of urinary retention
- Symptomatic and recurrent urinary tract infection (UTI)
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00410514
Start Date
December 1 2006
End Date
August 1 2008
Last Update
April 4 2014
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
Tuscon, Arizona, United States, 85712
2
Atherton, California, United States, 94027
3
Culver City, California, United States, 90232
4
Fresno, California, United States, 93720